Representative before the EPO

Technology company logo thumb
no operation time available
7 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
4 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
4 offices
Technology Company

We have observed 155 EP applications Gavin MacNicol Buchan has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after November 29, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12777344

AMIDATION PROCESS

IPC classification:
C07C 231/02
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12752786

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
A61K 31/38, A01N 43/06
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12767839

C5-C6 OXACYCLIC-FUSED THIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A61K 31/54, C07D 285/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12771100

5-SUBSTITUTED IMINOTHIAZINES AND THEIR MONO-AND DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A61K 31/541, A61K 31/54, C07D 417/14, C07D 417/12, C07D 417/04, C07D 279/12, A61P 25/28, A61P 25/16
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12779437

AMINOMETHYL BIARYL BENZOTRIAZOLE DERIVATIVES

IPC classification:
A61K 31/41, A01N 43/82, A01N 43/64
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP12789446

ARYLOXYMETHYL CYCLOPROPANE DERIVATIVES AS PDE10 INHIBITORS

IPC classification:
A61K 31/444
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12811318

TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF

IPC classification:
A61K 31/404, A01N 43/90, C07D 471/02
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12825781

2-SPIRO-SUBSTITUTED IMINOTHIAZINES AND THEIR MONO-AND DIOXIDES AS BACE INHIBITORS, COMPOSITIONS AND THEIR USE

IPC classification:
A61K 31/547
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
The patent has been granted
EP12748815

INHIBITING TRANSIENT RECEPTOR POTENTIAL ION CHANNEL TRPA1

IPC classification:
A61K 31/52, C07D 473/08, A61P 25/04
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Cubist Pharmaceuticals, Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Agent:
Jennifer Lucy Harris, Kilburn & Strode LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12831151

COMPOSITIONS AND METHODS FOR TREATING CANCER

IPC classification:
A01N 43/54
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12746994

CATHEPSIN CYSTEINE PROTEASE INHIBITORS

IPC classification:
A61P 19/10, A61P 19/00, A61P 3/10, C07C 317/32, A61K 31/165
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12838891

TRIAZOLYL PDE10 INHIBITORS

IPC classification:
A01N 43/38
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12776679

PROCESS FOR THE PREPARATION OF AN OREXIN RECEPTOR ANTAGONIST

IPC classification:
A61K 31/55, A01N 43/62, C07D 413/14, C07D 413/04, C07D 249/06
Applicant:
Merck Sharp & Dohme Ltd.
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
The patent has been granted
EP12842119

2,5-DISUBSTITUTED THIOMORPHOLINE OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A01N 43/00
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12780370

2-PYRIDYLOXY-4-NITRILE OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4545, C07D 417/14, C07D 413/14, C07D 409/14, C07D 401/14, A61P 25/20, A61P 25/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
The patent has been granted
EP12767320

PYRROLIDINE-FUSED THIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A61K 31/452, C07D 513/04, A61P 25/00
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12844222

MACROCYCLES THAT INCREASE p53 ACTIVITY AND THE USES THEREOF

IPC classification:
A61K 31/497
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12844517

PIPERIDINYL ALKYNE OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4545
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12843886

ISOXAZOLOPYRIDINE OREXIN RECEPTOR ANTAGONISTS

IPC classification:
C07D 498/04
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12843484

PARI-MUTUEL PREDICTION MARKETS AND THEIR USES

IPC classification:
G06Q 40/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP12760589

PIPERIDINONE CARBOXAMIDE SPIROHYDANTOIN CGRP RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/444, C07D 487/10
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12846357

NANO-SUSPENSION PROCESS

IPC classification:
A61K 9/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12845486

GAMMA SECRETASE MODULATORS

IPC classification:
A01N 43/00
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12768236

GAMMA SECRETASE INHIBITORS

IPC classification:
A61K 31/35, A01N 43/16
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP12846579

QUINOLINE CARBOXAMIDE AND QUINOLINE CARBONITRILE DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A01N 43/42
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
The patent has been granted
EP12850024

TRIAZOLOPYRIDINONE PDE10 INHIBITORS

IPC classification:
A01N 43/42
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12843015

BENZOXAZOLINONE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS

IPC classification:
A61K 31/423, C07D 263/54
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12784890

N-LINKED LACTAM M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

IPC classification:
A61K 31/405, A61K 31/40, A01N 43/38, C07D 491/10, C07D 487/08, C07D 471/04, C07D 417/08, C07D 405/14, C07D 403/08, C07D 403/06, C07D 401/14, C07D 401/08, C07D 401/06, C07D 209/64
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12860596

SUBSTITUTED PIPERIDINES AS HDM2 INHIBITORS

IPC classification:
A61K 31/497
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12779844

CYCLOHEXENE BENZOTRIAZOLE DERIVATIVES

IPC classification:
A61K 31/41, C07D 403/08, C07D 401/04, C07D 249/18
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12760168

PIPERIDINE CARBOXAMIDE SPIROHYDANTOIN CGRP RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/445, C07D 487/10, A61P 25/06
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12786166

N-LINKED QUINOLINEAMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

IPC classification:
A61K 31/4709, C07D 405/14, C07D 403/12, C07D 401/14, C07D 401/06, A61P 25/28
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12785978

N-METHYL TETRAHYDROQUINOLINE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

IPC classification:
A61K 31/517, C07D 471/04, A61P 25/28, A61P 25/18
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12779455

ALKYNE BENZOTRIAZOLE DERIVATIVES

IPC classification:
A61K 31/4192, C07D 403/06, C07D 401/06, C07D 249/18, A61P 25/18
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12817088

FUSED TRICYCLIC COMPOUNDS AS mTOR INHIBITORS

IPC classification:
A61K 31/519, A01N 43/90, C07D 519/00, C07D 487/14
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12801127

IMIDAZOPYRIDIN-2-ONE DERIVATIVES

IPC classification:
C07D 519/00, C07D 513/04, C07D 471/04
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12826375

PYRIMIDINE PDE10 INHIBITORS

IPC classification:
A61K 31/506, C07D 487/04, C07D 417/14, C07D 405/14, C07D 401/14, C07D 401/12, A61P 25/18
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14185954

Piperidinone carboxamide azaindane CGRP receptor antagonists

IPC classification:
A61K 31/519, A61K 31/437, C07D 471/10, A61P 9/08
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12823924

SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF

IPC classification:
A61K 31/42, C07D 417/04, C07D 413/04, C07D 277/82, C07D 277/60, C07D 263/58
Applicant:
Alectos Therapeutics Inc.
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12779601

HYDROXYMETHYL BIARYL BENZOTRIAZOLE DERIVATIVES

IPC classification:
A61K 31/4192, A01N 43/64, C07D 405/04, C07D 401/04, C07D 249/18
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13761100

BIS-QUARTERNARY CINCHONA ALKALOID SALTS AS ASYMMETRIC PHASE TRANSFER CATALYSTS

IPC classification:
C07D 453/04
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12829393

GAMMA SECRETASE INHIBITORS

IPC classification:
A61K 31/35, A01N 43/16, C07D 493/00, A61P 25/28
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13768805

IMIDAZOLYL METHYL PIPERIDINE T-TYPE CALCIUM CHANNEL ANTAGONISTS

IPC classification:
C07D 471/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13769724

1,3,4-OXADIAZOLE AND 1,3,4-THIADIAZOLE BETA-LACTAMASE INHIBITORS

IPC classification:
A61K 31/439, C07D 471/08, A61P 31/04
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Cubist Pharmaceuticals, Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Carpmaels & Ransford LLP
Status:
The patent has been granted
EP13769291

PREDICTIVE BIOMARKER USEFUL FOR CANCER THERAPY MEDIATED BY A CDK INHIBITOR

IPC classification:
C12Q 1/68
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13769216

THROMBIN INHIBITORS

IPC classification:
A61K 31/497
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13769389

ISOXAZOLE beta-LACTAMASE INHIBITORS

IPC classification:
A61K 31/46, C07D 451/06, A61P 31/00
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Cubist Pharmaceuticals, Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Carpmaels & Ransford LLP
Status:
The patent has been granted
EP12844405

NOVEL COMPOUNDS THAT ARE ERK INHIBITORS

IPC classification:
A61K 9/66
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12838133

1,3-SUBSTITUTED AZETIDINE PDE10 INHIBITORS

IPC classification:
A61K 31/506, C07D 417/14, C07D 413/14, C07D 405/14, C07D 403/14, C07D 401/14, A61P 25/22, A61P 25/18
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP13788440

PYRIDINE CGRP RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4709
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP13787989

PERMEABLE GLYCOSIDASE INHIBITORS AND USES THEREOF

IPC classification:
C07D 513/04
Applicant:
Alectos Therapeutics Inc.
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
The patent has been granted
EP13788254

SPIROLACTAM CGRP RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4523
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
The patent has been granted
EP13788382

HETEROCYCLIC CGRP RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4709
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP13788454

PROCESS FOR THE PREPARATION OF AN INTERMEDIATE FOR AN OREXIN RECEPTOR ANTAGONIST

IPC classification:
C12P 17/16
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP13787557

PROCESS FOR MAKING CGRP RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/519, A01N 43/90
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13796299

ISOTOPICALLY LABELED BIARYL UREA COMPOUNDS

IPC classification:
C07D 471/04
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP13794383

TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF

IPC classification:
A61K 31/17, A01N 47/28
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP13748245

HCV NS3 PROTEASE INHIBITORS

IPC classification:
A61K 31/407, A61K 31/343, C07D 491/107, A61P 31/14, A61P 1/16
Applicant:
Merck Canada Inc.
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13825992

alpha7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS AND USES THEREOF-I

IPC classification:
A61K 31/415, A61K 31/18, C07D 277/42, C07D 261/14, C07D 241/20, C07D 239/47, C07D 239/42, C07D 237/20, C07D 231/38, C07D 213/74, C07C 311/49, C07C 311/48, C07C 311/37, C07C 311/08
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13842584

SUBSTITUTED CYCLOPROPYL COMPOUNDS

IPC classification:
A61K 31/506, C07D 401/04, A61P 3/10
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP13845052

INHIBITORS OF IRAK4 ACTIVITY

IPC classification:
A61K 31/44, A61K 31/415, C07D 231/02
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
The patent has been granted
EP13845875

INHIBITORS OF IRAK4 ACTIVITY

IPC classification:
A61K 31/505, A61K 31/44
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13849733

N-SUBSTITUTED INDAZOLE SULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS

IPC classification:
A61K 31/416
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION REQUESTED
EP13849421

BENZOXAZOLINONE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS

IPC classification:
A61K 31/423, C07D 263/54
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP13848863

2-PYRIDYLOXY-3-SUBSTITUTED-4-NITRILE OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/551, C07D 409/14, C07D 401/14, A61P 3/04
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP15159929

Pyranyl aryl methyl benzoquinazolinone M1 receptor positive allosteric modulators

IPC classification:
A61K 31/517, C07D 491/04, C07D 471/04, C07D 417/14, C07D 405/14, C07D 405/04, C07D 401/14, A61P 25/28
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13854994

PROCESS FOR MAKING AGGLOMERATES USING ACOUSTIC MIXING TECHNOLOGY

IPC classification:
A61K 9/14
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION REQUESTED
EP13854671

CYCLOBUTYL BENZIMIDAZOLES AS PDE10 INHIBITORS

IPC classification:
A61K 31/4184
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP13855525

CYCLOPROPYL IMIDAZOPYRIDINE PDE10 INHIBITORS

IPC classification:
A61K 31/4188
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP13855567

SECONDARY ALCOHOL SUBSITUTED TRIAZOLES AS PDE10 INHIBITORS

IPC classification:
A61K 31/4184
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP13856456

PYRIMIDINE PDE10 INHIBITORS

IPC classification:
C07D 239/34
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP13856512

SUBSTITUTED PYRIDONE DERIVATIVES AS PDE10 INHIBITORS

IPC classification:
A61K 31/444
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP13857755

2-PYRIDYLAMINO-4-NITRILE-PIPERIDINYL OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/445
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP13811726

METHODS OF TREATING DIABETES BY ADMINISTERING A GLUCAGON RECEPTOR ANTAGONIST IN COMBINATION WITH A CHOLESTEROL ABSORPTION INHIBITOR

IPC classification:
A61K 45/06, A61K 31/435, A61K 31/415, A61K 31/404, A61K 31/397, A61P 3/10
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13862850

BACE INHIBITORS OF IMINOTHIADIAZINE DIOXIDES

IPC classification:
A61K 31/549, C07D 285/18, A61P 25/28
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
The patent has been granted
EP13865833

NOVEL 2-PYRIDINECARBOXAMIDE DERIVATIVES, COMPOSITIONS CONTAINING SUCH COMPOUNDS, AND METHODS OF TREATMENT

IPC classification:
C07D 401/14
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13864999

NOVEL GLUCOKINASE ACTIVATOR COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS, AND METHODS OF TREATMENT

IPC classification:
C07F 9/32
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13868947

GLYCOSIDASE INHIBITORS AND USES THEREOF

IPC classification:
C07D 513/04, A61P 11/02
Applicant:
Merck & Co. Inc.
Applicant:
Alectos Therapeutics Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13864272

C6-AZASPIRO IMINOTHIADIAZINE DIOXIDES AS BACE INHIBITORS

IPC classification:
A61K 31/549, A61K 31/54, A01N 43/836, C07D 285/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13866141

2-PYRIDYLOXY-4-ESTER OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4545, C07D 401/14, A61P 25/20
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP13865601

2-PYRIDYLOXY-3-NITRILE-4-SUBSTITUTED OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4192, C07D 413/02, C07D 413/00, C07D 401/14
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP13864049

3-ESTER-4-SUBSTITUTED OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4192, C07D 413/02, C07D 413/00, C07D 401/14
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP13864070

C5-SPIRO IMINOTHIADIAZINE DIOXIDES AS BACE INHIBITORS

IPC classification:
A61K 31/519, A61K 31/497
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP13865620

C5, C6 OXACYCLIC-FUSED IMINOTHIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS

IPC classification:
A61K 31/54, C07D 279/12
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13867977

PIPERAZINE-SUBSTITUTED [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES

IPC classification:
A61K 31/519, A61K 31/4985
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP13866588

HETEROBICYCLO-SUBSTITUTED-[1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES

IPC classification:
A61K 31/519, A61K 31/4985, C07D 487/04, A61P 25/16
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP14740325

4-FLUOROPIPERIDINE OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4523, A61K 31/445
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP14741091

INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL

IPC classification:
C07D 473/08
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Cubist Pharmaceuticals, Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP14743190

BTK INHIBITORS

IPC classification:
C07D 213/75
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14743619

BTK INHIBITORS

IPC classification:
A61K 31/52, A61K 31/519, C07D 519/00, C07D 487/04, C07D 253/06
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14749562

TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HEPATITIS C

IPC classification:
A61K 31/44, A01N 43/42
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14748737

TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HEPATITIS C

IPC classification:
A61K 31/397, A01N 43/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14760553

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
C07D 231/56, A61K 31/415
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP14760677

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
C07D 231/56, A61K 31/415
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP14759654

2-PYRIDYLOXY-4-ETHER OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4545
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP14761162

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
C07D 231/56, A61K 31/415
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP14761134

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
C07D 231/56, A61K 31/415
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP14770245

S-IMINO-S-OXO IMINOTHIADIAZINE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
C07D 285/00, A61K 31/55
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP14770391

S-IMINO-S-OXO IMINOTHIAZINE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A61K 31/55
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP14767603

C2-AZASPIRO IMINOTHIAZINE DIOXIDES AS BACE INHIBITORS

IPC classification:
C07D 417/04, A61P 25/28, A61K 31/547
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14775102

ADAPTED LEPIDOPTERAN INSECT CELLS FOR THE PRODUCTION OF RECOMBINANT PROTEINS

IPC classification:
C12N 5/10
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14768510

SUBSTITUTED PYRIDIZINONE DERIVATIVES AS PDE10 INHIBITORS

IPC classification:
C07D 237/02, A61K 31/501
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14770224

CRYSTALLINE FORM OF A BETA-LACTAMASE INHIBITOR

IPC classification:
C07D 487/04, C07F 1/04
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP14787452

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS AND USES THEREOF - III

IPC classification:
A61P 29/00, A61P 25/28, A61K 31/506, A61K 31/4427, C07D 401/14, C07D 403/12, C07D 401/12
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION REQUESTED
EP14787746

HALO AND TRIFLUOROMETHYL SUBSTITUTED OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4709
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP14788669

HYDROXY-SUBSTITUTED OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4709
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP14788108

2-HYDROXYMETHYL-SUBSTITUTED OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4709
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP14725702

SLC2A TRANSPORTER INHIBITORS

IPC classification:
A61P 3/00, A61P 25/00, A61P 29/00, A61P 37/00, A61P 35/00, A61K 31/4985, A61K 31/437, C07D 519/00, C07D 487/04, C07D 471/04
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Jeffrey Nicholas Daniels, Page White & Farrer
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP14810345

PREPARATION OF TERT-BUTYL 4-((1R,2S,5R)-6- (BENZYLOXY)-7-0X0-1,6-DIAZABICYCL0[3.2.I]OCTANE-2- CARBOXAMIDO)PIPERIDINE-1-CARBOXYLATE

IPC classification:
C07D 211/00, C07D 491/02
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP14814205

DENGUE VIRUS VACCINE COMPOSITIONS AND METHODS OF USE THEREOF

IPC classification:
A61K 39/193, A61K 39/12
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14823386

SUBSTITUTED AMIDOPYRAZOLE INHIBITORS OF INTERLEUKIN RECEPTOR-ASSOCIATED KINASES (IRAK-4)

IPC classification:
C07D 487/04, A61K 31/497, A61K 31/519
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP12741504

POSITIVE ALLOSTERIC MODULATORS OF THE ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR AND USES THEREOF.

IPC classification:
A61P 25/28, A61K 31/4409, C07D 317/58, A61P 25/24, A61K 31/44, C07D 277/46, A61P 25/22, A61K 31/426, C07D 231/40, A61P 25/18, A61K 31/415, C07D 213/82, A61P 25/16, A61K 31/36, C07D 213/81, A61P 25/14, A61K 31/167, C07C 233/60, A61P 25/00, C07C 233/57
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Agent:
Grünecker Patent- und Rechtsanwälte PartG mbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14833751

OXAZOLE OREXIN RECEPTOR ANTAGONISTS

IPC classification:
C07D 413/04, A61K 31/4525, A61K 31/454, A61K 31/422
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14834750

THIAZOLE OREXIN RECEPTOR ANTAGONISTS

IPC classification:
C07D 413/04, A61K 31/4525, A61K 31/454, A61K 31/422
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14836140

METHODS AND COMPOSITIONS FOR CO-EXPRESSION OF POLYPEPTIDES OF INTEREST AND IL6

IPC classification:
C12N 5/02, C12N 15/00, C12N 15/87, C12N 5/07
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP15197990

IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
C07B 59/00, C07D 495/04, C07D 471/04, C07D 417/14, C07D 417/12, C07D 417/04, C07D 403/12, C07D 403/04, C07D 401/14, C07D 401/12, C07D 285/18, A61K 31/54
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP14837218

TREATING CANCER WITH A COMBINATION OF A PD-1 ANTAGONIST AND DINACICLIB

IPC classification:
A01N 43/90, C07K 14/475, C07K 16/00, A61K 39/395
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14837215

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
A61K 31/415, A01N 43/56, A01N 43/52
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14761460

MODULATION OF TUMOR IMMUNITY

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP14840648

2,2-DIFLUORODIOXOLO A2A RECEPTOR ANTAGONISTS

IPC classification:
A01N 43/60, A01N 43/58
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP14844006

C5-SPIRO IMINOTHIAZINE DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A61K 31/547
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14845934

TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF

IPC classification:
A61P 29/00, A61K 31/41, A61K 31/17
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP14854507

METHOD OF OBTAINING THERMOSTABLE DRIED VACCINE FORMULATIONS

IPC classification:
A61K 39/12
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14854498

THERMOSTABLE RESPIRATORY SYNCTIAL VIRUS (RSV) VACCINE COMPOSITIONS

IPC classification:
A61P 31/14, A61K 9/19, A61K 39/12
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14854464

METHOD OF MICROWAVE VACUUM DRYING SPHERICAL-SHAPED PELLETS OF BIOLOGICAL MATERIALS

IPC classification:
C07K 1/36
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14856821

GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF USE

IPC classification:
C07D 209/18, A61P 3/10, A61K 31/404
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14861985

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
C07D 231/56, A61K 31/415
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14866477

BICYCLOAMINE-SUBSTITUTED-N-BENZENESULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS

IPC classification:
C07D 487/04
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14870360

IMMUNOHISTOCHEMICAL PROXIMITY ASSAY FOR PD-1 POSITIVE CELLS AND PD-LIGAND POSITIVE CELLS IN TUMOR TISSUE

IPC classification:
A61P 35/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14870699

BTK INHIBITORS

IPC classification:
A61P 3/10, A61P 19/02, A61K 31/437
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14872269

BTK INHIBITORS

IPC classification:
A61P 3/10, A61P 19/02, A61K 31/437
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14872471

C-6 SPIROCARBOCYCLIC IMINOTHIADIAZINE DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
C07D 285/15
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14872286

IFN-GAMMA GENE SIGNATURE BIOMARKERS OF TUMOR RESPONSE TO PD-1 ANTAGONISTS

IPC classification:
C12Q 1/68
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14872578

MEDIA MILLING PROCESS FOR THE MANUFACTURE OF ACTIVE PHARMACEUTICAL INGREDIENTS IN PROPELLANTS

IPC classification:
A61J 3/02
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14871886

IMINOTHIADIAZEPANE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A61K 31/547
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14870931

NOVEL TRICYCLIC CALCIUM SENSING RECEPTOR ANTAGONISTS

IPC classification:
C07D 307/91, C07D 471/04
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14873215

PYRIMIDONE CARBOXAMIDE COMPOUNDS AS PDE2 INHIBITORS

IPC classification:
A61P 25/28, A61P 25/22, A61P 25/18, A61K 31/513, C07D 405/14, C07D 405/12, C07D 401/14, C07D 401/12, C07D 239/36
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15740828

METALLO-BETA-LACTAMASE INHIBITORS

IPC classification:
C07D 257/04, A61K 31/4184, A61K 31/41
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15746725

NOVEL DISINTEGRATION SYSTEMS FOR PHARMACEUTICAL DOSAGE FORMS

IPC classification:
A61K 9/20
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15746174

PHARMACEUTICAL COMPOSITION OF SELECTIVE HCV NS3/4A INHIBITORS

IPC classification:
A61P 31/12, A61K 31/498
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15746768

TABLET FORMULATION FOR CGRP-ACTIVE COMPOUNDS

IPC classification:
A61K 9/26, A61K 31/437, C07D 221/02
Applicant:
Merck & Co. Inc.
Agent:
Hoffmann Eitle PartmbB
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15746312

ANTIBODIES THAT BIND TO HUMAN TAU AND ASSAY FOR QUANTIFYING HUMAN TAU USING THE ANTIBODIES

IPC classification:
A61K 39/395, C07K 16/18
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15759159

HIV PROTEASE INHIBITORS

IPC classification:
A61K 31/5377
Applicant:
Merck & Co. Inc.
Applicant:
Merck Canada Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15760695

PIPERAZINE DERIVATIVES AS HIV PROTEASE INHIBITORS

IPC classification:
C07D 241/36, C07D 281/10
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15761797

PURIFYING INSULIN USING CATION EXCHANGE AND REVERSE PHASE CHROMATOGRAPHY IN THE PRESENCE OF AN ORGANIC MODIFIER AND ELEVATED TEMPERATURE

IPC classification:
C07K 1/00, A61K 38/00, A61K 38/28
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15715934

4'-SUBSTITUTED NUCLEOSIDE-DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS

IPC classification:
A61P 1/16, A61K 31/7076, A61K 31/7064, C07H 19/14, C07H 19/06, C07D 487/04
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15774282

PRODRUGS OF HIV REVERSE TRANSCRIPTASE INHIBITORS

IPC classification:
A61K 31/513, A61K 31/506, A61K 31/501
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15773458

PHOSPHATE BASED LINKERS FOR INTRACELLULAR DELIVERY OF DRUG CONJUGATES

IPC classification:
A61K 47/24
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15779184

FACTOR IXA INHIBITORS

IPC classification:
C07D 207/02, C07D 261/20, C07D 413/14
Applicant:
Mochida Pharmaceutical Co Ltd
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15780578

FACTOR IXA INHIBITORS

IPC classification:
C07D 207/02, C07D 261/20, C07D 413/14
Applicant:
Mochida Pharmaceutical Co Ltd
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15782608

PHARMACEUTICAL SALTS OF AN OREXIN RECEPTOR ANTAGONIST

IPC classification:
C07D 413/14, A61K 31/423, A61K 31/551
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15783339

FACTOR XIa INHIBITORS

IPC classification:
C07D 498/20, A61K 31/438, C07D 471/10
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15789928

BETA-TETRAZOLYL-PROPIONIC ACIDS AS METALLO-BETA-LACTAMASE INHIBITORS

IPC classification:
A61K 31/192, A61K 31/41
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15800524

FACTOR XIA INHIBITORS

IPC classification:
A61K 31/167, A61K 31/4192, A61K 31/44
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15803641

C2-CARBOCYCLIC IMINOTHIAZINE DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
C07D 417/14
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature